Greenwich Lifesciences Inc - ESG Rating & Company Profile powered by AI
The page displays a zero-cost E,S&G analysis covering Greenwich Lifesciences Inc. Comprehensive ESG assessment of Greenwich Lifesciences Inc are reached by logging in. This webpage of Greenwich Lifesciences Inc was assembled by All Street Sevva using advanced NLP.
Greenwich Lifesciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 1.6, social score of 4.8 and governance score of 5.3.
3.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1443 | XSpray Pharma AB (publ) | 4.0 | High |
| 1443 | Zhong Yuan Bio-Technology Holdings Ltd | 4.0 | High |
| ... | ... | ... | |
| 1476 | Greenwich Lifesciences Inc | 3.9 | Medium |
| 1476 | Anebulo Pharmaceuticals Inc | 3.9 | Medium |
| 1476 | Anhui Sunhere Pharmaceutical Excipients Co Ltd | 3.9 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Greenwich Lifesciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Greenwich Lifesciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Greenwich Lifesciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Greenwich Lifesciences Inc offer flexible work?
Sign up for free to unlockDoes Greenwich Lifesciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Greenwich Lifesciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Greenwich Lifesciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose water use targets?
Sign up for free to unlockDoes Greenwich Lifesciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Greenwich Lifesciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Greenwich Lifesciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Greenwich Lifesciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Greenwich Lifesciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Greenwich Lifesciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Greenwich Lifesciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose its waste policy?
Sign up for free to unlockDoes Greenwich Lifesciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose energy use targets?
Sign up for free to unlockDoes Greenwich Lifesciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Greenwich Lifesciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Greenwich Lifesciences Inc
These potential risks are based on the size, segment and geographies of the company.
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent recurrence of breast cancer following surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.